药物信息为Isolyte P in 5% Dextrose (Multi-Electrolyte Injection) (B. Braun Medical Inc.): DESCRIPTION

Each 100 mL of Isolyte P (Multi-Electrolyte Injection) in 5% Dextrose contains: Hydrous Dextrose USP 5 g; Sodium Acetate Trihydrate USP 0.32 gPotassium Chloride USP 0.13 g; Magnesium Chloride Hexahydrate USP 0.031 gDibasic Potassium Phosphate USP 0.026 g; Water for Injection USP qs

pH adjusted with Hydrochloric Acid NFpH: 5.0 (4.0–6.0) Calories per liter: 170Calculated Osmolarity: 340 mOsmol/liter

Concentration of Electrolytes (mEq/liter): Sodium 23; Chloride 29Acetate (CH₃COO^-) 23; Potassium 20; Magnesium 3; 1.5 mmole P/literPhosphate (HPO) 3

Isolyte P in 5% Dextrose is sterile, nonpyrogenic, and contains no bacteriostatic or antimicrobial agents or added buffers. This product is intended for intravenous administration.

The formulas of the active ingredients are:

Ingredients	MolecularFormula	MolecularWeight
Sodium Acetate Trihydrate USP	CH3COONa•3H2O	136.08
Potassium Chloride USP	KCl	74.55
Magnesium Chloride Hexahydrate USP	MgCl2•6H2O	203.30
Dibasic Potassium Phosphate USP	K2HPO4	174.18
Hydrous Dextrose USP		198.17

The EXCEL Container is Latex-free, PVC-free, and DEHP-free.

The plastic container is made from a multilayered film specifically developed for parenteral drugs. It contains no plasticizers. The solution contact layer is a rubberized copolymer of ethylene and propylene. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials. The container-solution unit is a closed system and is not dependent upon entry of external air during administration. The container is overwrapped to provide protection from the physical environment and to provide an additional moisture barrier when necessary. Exposure to temperatures above 25°C/77°F during transport and storage will lead to minor losses in moisture content. Higher temperatures lead to greater losses. It is unlikely that these minor losses will lead to clinically significant changes within the expiration period.

Addition of medication should be accomplished using complete aseptic technique.

The closure system has two ports; the one for the administration set has a tamper evident plastic protector and the other is a medication site. Refer to the Directions for Use of the container.